Invicta Diagnostic Ltd (INVICTA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Invicta Diagnostic Ltd on NSE and BSE, with an AI summary of each filing.
Invicta Diagnostic Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 19, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 20 Sept 2026, 3:47 am
Invicta Diagnostic Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 19, 2026
Annual General Meeting · 20 Sept 2026, 12:40 am
Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on September 18, 2026 wherein Board considered and approved the proposed business outlook and forward-looking guidance to be communicated by the Chairman & Managing Director and Chief Financial Officer to the Members at the Company s 3rd Annual General Meeting scheduled to be held on Saturday, 19th September, 2026.
Annual General Meeting · 18 Sept 2026, 7:07 pm
Invicta Diagnostic Limited has informed the Exchange about Commencement of commercial operations of Centres at Shegaon Diagnostic LLP (a Subsidiary LLP), and Porteus Pathogenius LLP (a Step-Down Subsidiary LLP)
Others (Uncategorized) · 17 Sept 2026, 6:32 pm
Invicta Diagnostic Expands Operations with New Centres in Shegaon and Pune Invicta Diagnostic commenced commercial operations at two new centres on 17th Sep'26 through its subsidiaries. Subsidiary Shegaon Diagnostic LLP initiated CT scan services with an approximate investment of Rs. 60 lakhs, while step-down subsidiary Porteus Pathogenius LLP launched pathology services in Pune with an investment of around Rs. 10 lakhs. Both expansions are funded entirely via internal company funds. This move aligns with Invicta's long-term strategy to scale its Mumbai operating model into high-potential urban markets by partnering with local clinicians.
Invicta Diagnostic Limited has informed the Exchange about Copy of Newspaper Publication of AGM Notice
Annual General Meeting · 28 Aug 2026, 12:36 am
Invicta Diagnostic Limited has informed the Exchange regarding Notice of 3rd Annual General Meeting to be held on September 19, 2026
Annual General Meeting · 25 Aug 2026, 11:49 pm
Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on August 25, 2026.
Outcome · 25 Aug 2026, 11:40 pm
Invicta Diagnostic Announces AGM and Key Management Appointment Invicta Diagnostic's board approved its 3rd AGM for 19th Sep'26 to adopt FY26 financial statements. The board also approved the appointment of Mr. Sanket Vinod Jain as Managing Director for a three-year term from 29th Jul'26 to 28th Jul'29, with an annual remuneration of ₹7,20,000. Additionally, M/s Shrenik Nagaonkar & Associates were appointed as Secretarial Auditor for five years from FY 2025-26. The record date for AGM e-voting eligibility is set for 12th Sep'26.
Invicta Diagnostic Limited has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 30 Jul 2026, 12:25 am
Invicta Diagnostic Limited has informed the Exchange regarding Outcome of Board Meeting held on July 29, 2026. Board at its meeting held today1. The Board took on record and accepted the resignation of Mr. Rohit Prakash Srivastava (DIN: 01432112) from the office of Whole-time Director (Finance) and Director of the Company2. The Board accepted the resignation of Ms. Konica Rohit Srivastava from the office of Manager of the Company3. The Board appointed Mr. Sanket Vinod Jain (DIN: 08299039) as Man
Outcome · 29 Jul 2026, 11:28 pm
Invicta Diagnostic Announces MD Appointment and Key Management Changes Invicta Diagnostic announced key leadership changes effective 29 Jul'26. Mr. Sanket Vinod Jain was appointed Managing Director for a 3-year term. Mr. Rohit Prakash Srivastava resigned as Whole-time Director to focus on his role as CFO. Ms. Konica Rohit Srivastava resigned as Manager. Additionally, the Board approved the sale of its 50% stake in associate MSCRIBEIT INFOTECH LLP, which has nil turnover and a net worth of Rs. 1.59 Lakhs, for Rs. 50,000. The Stakeholders Relationship Committee was also reconstituted following a resignation.
Invicta Diagnostic Limited has informed the Exchange about Board Meeting to be held on 29-Jul-2026 to consider Other business.
Intimation · 24 Jul 2026, 2:19 am
Invicta Diagnostic Schedules Board Meeting Invicta Diagnostic Limited will hold a Board Meeting on 29-Jul'26. The company informed the exchange that the agenda includes consideration of other unspecified business matters.
1. To consider and take on record the resignation of Mr. Rohit Prakash Srivastava (DIN: 01432112) from the office of Whole-time Director and Director of the Company and to consider waiver of the notice period.2. To consider and take on record the resignation of Ms. Konica Rohit Srivastava from the office of Manager (Key Managerial Personnel) of the Company and to consider waiver of the notice period.3. To consider and approve the appointment of Mr. Sanket Vinod Jain, DIN-08299039 Director of the
Intimation · 23 Jul 2026, 7:18 pm
Invicta Diagnostic Announces Board Meeting on Management Reshuffle and Asset Sale Invicta Diagnostic's board will meet on 29 Jul'26 to consider key management changes and an asset disposal. Rohit Prakash Srivastava has resigned as Whole-time Director to focus on his CFO duties. KMP Konica Rohit Srivastava has also resigned. The board will also consider appointing Sanket Vinod Jain as Managing Director. A proposal to sell its 50% stake in associate MSCRIBEIT INFOTECH LLP, which has nil assets and liabilities and no business operations, will also be reviewed at the meeting.
Invicta Diagnostic Limited has informed the Exchange regarding Change in Director(s) of the company.
Intimation · 23 Jul 2026, 7:13 pm
Invicta Diagnostic Board Meeting to Consider Key Resignations and Management Changes Invicta Diagnostic has scheduled a Board Meeting on 29 Jul'26 to consider several key changes. The agenda includes the resignation of Mr. Rohit Prakash Srivastava as Whole-time Director, who will continue as CFO. The resignation of Ms. Konica Rohit Srivastava from her role as Manager (KMP) will also be reviewed. Additionally, the board will discuss the appointment of Mr. Sanket Vinod Jain as Managing Director and the disposal of its 50% stake in associate entity MSCRIBEIT INFOTECH LLP, which has no business operations.
Invicta Diagnostic Limited has informed the Exchange about change in Management of Porteus Pathogenius LLP, a subsidiary of Porteus Medical LLP, which is a subsidiary of Invicta Diagnostic Limited
Change in Management · 21 Jul 2026, 2:26 am
Invicta Diagnostic Reports Partner Change in Step-down Subsidiary On 20 Jul'26, Invicta Diagnostic announced a partner change in its step-down subsidiary, Porteus Pathogenius LLP. Mr. Mayur Shivdas Kasat has been inducted as a Designated Partner, acquiring the 49% interest previously held by the retiring partner, Mr. Vishwajeet Arvind Burungale. Porteus Medical LLP continues to hold the controlling 51% stake. The company stated this management change is not expected to have any material financial or operational impact, as the controlling interest remains unchanged.
Invicta Diagnostic Limited has informed the Exchange regarding a press release dated July 01, 2026, titled "Invicta Diagnostic Limited Starts Commercial Operations at Pune Centre; Total Network Reaches 10 Diagnostic Centres".
Press Release · 02 Jul 2026, 2:17 am
Invicta Diagnostic Commences Pune Operations, Expanding Network to 10 Centres Invicta Diagnostic Limited (NSE: INVICTA) commenced commercial operations at its new Pune centre on 30 Jun'26 through its subsidiary, Porteus Medical LLP. This is the company's second centre outside the Mumbai Metropolitan Region, expanding its total network to 10 diagnostic centres and one centralised lab across Maharashtra. The new facility offers a comprehensive range of services, including MRI, CT scans, and pathology. This expansion aligns with Invicta's strategy to replicate its Mumbai model in high-potential urban markets to accelerate growth.
Invicta Diagnostic Limited has informed the Exchange that Company's Subsidiary LLP i.e. Porteus Medical LLP has established its diagnostic services centre at Pune Centre and it has started commercial operations on 30 June, 2026
Others (Uncategorized) · 01 Jul 2026, 12:37 am
Invicta Diagnostic Launches Pune Centre, Expanding Regional Footprint Invicta Diagnostic's subsidiary, Porteus Medical LLP, commenced commercial operations at its new Pune diagnostic centre on 30 Jun'26. The company has invested ₹416 lakhs, funded internally, to establish the facility which will offer MRI, CT scan, mammography, sonography, pathology, and X-ray services. This expansion increases the company's network to 10 diagnostic centres and aligns with its strategy to replicate its Mumbai model in other high-potential urban markets to accelerate growth and market penetration.